Trade Summary

5 days ago, Ezekowitz Alan, serving as Dir at Fulcrum Therapeutics, Inc. (FULC), sold 18,000 shares at $3.65 per share, for a total transaction value of $65,613.60. Following this transaction, Ezekowitz Alan now holds 10,927 shares of FULC.

This sale represents a 62.23% decrease in Ezekowitz Alan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 26, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 30, 2026 at 4:30 PM ET, 4 days after the trade was made.

Fulcrum Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.